Delivery Order SPE2DB20D2104-SPE2DB23FR54C
Award Date 12/21/22
Potential Completion Date 12/22/22
Potential Value $4.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with 4,563,829,052 units of the medication Ondansetron ODT 4 mg tablets. The $15,894.31 firm fixed-price delivery order has a completion date of March 4, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,177,428 units of Ondansetron ODT 8 mg tablets. The $4,191.53 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) on October 22, 2024, with a completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,561,375,553 units of the medication Ondansetron ODT 4 mg tablets. The $8,290.26 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on June 29, 2023, with a completion date of June 30, 2023. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $48,748.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,250,472 units of the drug Ondansetron ODT 4 mg tablet, with a performance period through January 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,450.12 firm fixed-price delivery order is for the supply of 4563078403 Ondansetron ODT 4 MG Tablet 30S. The contract has an ultimate completion date of December 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,131.02 fixed-price delivery order is for the supply of 4,566,738,644 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,997.57 firm fixed-price delivery order is for the supply of 4,567,760 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,335.35 firm fixed-price delivery order is for the supply of 4,568,189,475 units of the prescription medication Ondansetron ODT 4 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The contract covers the supply of 4,566,719,877 units of the generic drug Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price contract with a ceiling value of $2,677.43 and a completion date...